Administration of MSCs led to a 50% reduction in the expression of TNFα (p = 0.01), a 34% reduction of IL1β (p = 0.02) and a 60%reduction of IL6 (p = 0.006) 7 days after infection (Figure 7a–c). The gene discussed is IL6; the disease is infection.